LEP and cancer: This promotes its transcription and FAO, which in turn promotes the proliferation of breast cancer stem cells (BCSCs) and cancer cell drug resistance.112 Thus, inhibiting JAK, FAO, or leptin inhibits BCSC self-renewal and re-sensitizes cancer cells to chemotherapeutic agents.